Millennium Pharmaceuticals, Inc. (MLNM)

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Millennium Pharmaceuticals, Inc. (MLNM)

An SI Board Since February 1997

Posts	SubjectMarks	Bans	Symbol
3044	135	0	MLNM

Emcee: icanpickem	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
1669	<b>Goldman-Sachs' take tonite:</b> Yesterday, Millennium entere	PCSS	-	6/30/2003
1668	Actually, I hope the market perceives this as an absolutely atrocious deal and t	Ian@SI	-	6/30/2003
1667	My take is that it was a reaction to the low upfront payment. My hope though is	Madharry	-	6/30/2003
1666	Perhaps the negative reaction is impatience over the fact that the timeline for	ewolf	-	6/30/2003
1665	Xoma Gets $4 Million From Millennium Pharmaceuticals DOW JONES NEWSWIRES WASHI	Icebrg	-	6/30/2003
1664	J&J agrees $750m deal to market drug By Victoria Griffith in Boston Publishe	Icebrg	-	6/30/2003
1663	>>(ii) will profitability objectives be hit each year in 2003, 4, 5 , 6, o	Icebrg	-	6/30/2003
1662	>>is this a buying opportunity ?>> Oh yes, I think so. The question	Icebrg	-	6/30/2003
1661	if I hear you correctly (?) the mkt is overreacting negatively to what should/c	PCSS	-	6/30/2003
1660	>>(iii) is the royalty rate around 25% ? - - no direct answer>> If	Icebrg	-	6/30/2003
1659	6/30/03 velcade deal 1. 2 main objectives: retaining 100% of US market for al	software salesperson	-	6/30/2003
1658	but ..... Reuters UPDATE - Millennium to market cancer drug Velcade with J&	PCSS	-	6/30/2003
1657	Looks like JNJ wins the opportunity to partner Velcade with MLNM... Potential p	Ian@SI	-	6/30/2003
1656	These sound like great results to me. Am I missing something? How do the side ef	Madharry	-	6/29/2003
1655	MLNM was up 3.92% for the week. However, as of Friday's close, biotech stock	blackmerlin	-	6/29/2003
1654	Cancer Drug VelcadeTM Holds Promise for a Novel Treatment of Mantle Cell Lymphom	Icebrg	-	6/29/2003
1653	Stock was up a little after hours.	Madharry	-	6/27/2003
1652	Based on today and the time frame, it wouldn't be surprising to see the velc	ewolf	-	6/27/2003
1651	Millennium Pharmaceuticals initiated with "market perform" Message 19	Icebrg	-	6/27/2003
1650	Cytogen Bone Pain Drug Could Help Multiple Myeloma Care Wednesda	SemiBull	-	6/25/2003
1649	Velcade(TM) (Bortezomib) for Injection Phase II (Summit) Multiple Myeloma Study	SemiBull	-	6/25/2003
1648	From Forbes: Some miracle drugs emerge from eureka moments, but more often a ne	mopgcw	-	6/23/2003
1647	>>The Journal of Immunology, 2003, 171: 88-95. Inhibition of Constitutive	tuck	-	6/20/2003
1646	XOMA Initiates Phase I Clinical Trial of MLN2201, an Inhibitor of Vascular Infla	Icebrg	-	6/19/2003
1645	Proteasome Inhibition: A New Pathway in Cancer Therapy Julian Adams, PhD; Heinz	Icebrg	-	6/15/2003

Go to reply# or date (mm/dd/yy):